查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1586124

心律管理設備市場：按產品、最終用戶分類 - 2025-2030 年全球預測

Cardiac Rhythm Management Devices Market by Product (Cardiac Resynchronization Therapy, Defibrillators, Pacemakers), End-User (Ambulatory Surgery Centers, Hospitals, Clinics, & Cardiac Centers) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

」

2023年心律管理設備市場價值為225.7億美元，預計2024年將達248億美元，複合年成長率為9.98%，到2030年將達到439.4億美元。

心律管理（CRM）設備的市場範圍包括旨在治療心律不整和管理心率的設備。這包括心律調節器調節器、心臟去顫器和心臟再同步治療設備等。這些設備對於降低與心臟疾病相關的發病率和死亡率以及改善慢性心臟疾病患者的生活品質至關重要。應用主要在醫院和心臟診所，最終用途包括供醫療保健專業人員使用的植入式和外部版本。心血管疾病日益普及、強調小型化和提高電池壽命的技術進步以及全球人口老化對市場成長產生了重大影響。醫療基礎設施不斷擴大的新興市場機會已經成熟，公司有空間引入創新且具成本效益的解決方案。此外，透過與 IoT 和 CRM 設備整合進行即時監控在改善患者治療效果方面具有開拓的潛力。

主要市場統計
基準年[2023] 225.7億美元
預測年份 [2024] 248億美元
預測年份 [2030] 439.4億美元
複合年成長率（%） 9.98%

儘管存在成長潛力，但高成本和嚴格的監管核准等挑戰可能會阻礙市場擴張。對連網型設備的網路安全風險和裝置植入併發症的擔憂也是障礙。其局限性包括獲得醫療保健的地區差異以及低收入地區患者通常無法負擔的設備和手術成本高昂。永續的業務成長需要專注於提高設備生物相容性、延長電池壽命和增強遠端監控能力的技術創新。此外，探索與高科技公司建立合作夥伴關係以提高資料分析能力可以提供競爭優勢。市場充滿活力，既有現有進入者，也有新進入者，並且不斷進行研究和開發工作。公司應專注於開發全面的價值提案，包括售後服務和與更廣泛的醫療保健系統整合的智慧型設備解決方案。這些見解可用於指導推動技術進步和進入新市場的策略性舉措。

市場動態：揭示快速發展的心律管理設備市場的關鍵市場洞察

供需的動態交互作用正在改變心律管理設備市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 心臟衰竭患者增加
    • 擴大光電體積描記技術在穿戴式裝置中的應用，用於偵測心房顫動 (AFib)
    • 增加 CM 和 CRM 設備研究的投資和津貼
  • 市場限制因素
    • 與心律管理設備相關的產品回想
  • 市場機會
    • 先進心律管理設備簡介
    • 醫療保健服務支出增加
  • 市場挑戰
    • 缺乏具備心電圖和心臟方面知識和專業知識的熟練專業人員

波特五力：駕馭心律管理設備市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解心律管理設備市場的外部影響

外部宏觀環境因素在塑造心律管理設備市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解心律管理設備市場的競爭格局

心律管理設備市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣心律管理設備市場供應商的績效評估

FPNV定位矩陣是評估心律管理設備市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃心律管理設備市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對心律管理設備市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心臟衰竭的發生率增加
      • 穿戴式裝置中擴大使用血管脈動血流量記錄法來檢測心房顫動 (AFib)
      • 增加 CM 和 CRM 設備研究的投資和津貼
    • 抑制因素
      • 與心律管理設備相關的產品回想
    • 機會
      • 先進心律管理設備簡介
      • 醫療保健服務支出增加
    • 任務
      • 缺乏具備心電圖和心血管疾病知識和專業知識的熟練專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章心律管理設備市場：依產品

  • 心臟再同步治療
    • CRT心臟去顫器
    • CRT心律調節器
  • 心臟去顫器
    • 體外去顫心臟去顫器
      • 自動體外電擊器
      • 手動體外電擊器
      • 心臟去顫器
    • 植入式心臟整流去顫器
      • S-ICD
      • T-ICD
  • 心律調節器
    • 外部的
    • 嵌入式

第7章心律管理設備市場：依最終使用者分類

  • 門診手術中心
  • 醫院、診所、心臟中心

第8章美洲心律管理設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區心律管理設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲心律管理設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • ACS Diagnostics
  • Alivecor, Inc.
  • Asahi Kasei Corporation
  • Bexen Cardio
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BPL Medical Technologies Private Limited
  • Defibtech LLC by Nihon Kohden Corporation
  • General Electric Company
  • HeartSine Technologies, Ltd. by Stryker Corporation
  • Hill-Rom Holdings, Inc. by Baxter International, Inc.
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co.,Ltd.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Narang Medical Ltd.
  • TZ Medical, Inc.
  • ZOLL Medical Corporation
」
Product Code: MRR-A339DAEFAFE8

The Cardiac Rhythm Management Devices Market was valued at USD 22.57 billion in 2023, expected to reach USD 24.80 billion in 2024, and is projected to grow at a CAGR of 9.98%, to USD 43.94 billion by 2030.

The scope of the cardiac rhythm management (CRM) devices market encompasses devices designed to treat arrhythmias and manage heart rate. This includes pacemakers, defibrillators, and cardiac resynchronization therapy devices. They are crucial in reducing morbidity and mortality associated with cardiac disorders, enhancing the quality of life for patients with chronic heart conditions. The application scope extends primarily to hospitals and specialized cardiac clinics with an end-use range that includes both implantable and external devices utilized by healthcare professionals. Market growth is significantly influenced by the increasing prevalence of cardiovascular diseases, advancements in technology focusing on miniaturization and better battery life, and an aging global population. Opportunities are ripe in emerging markets where healthcare infrastructure is expanding, providing openings for companies to introduce innovative, cost-effective solutions. Moreover, IoT integration with CRM devices for real-time monitoring presents untapped potential for improved patient outcomes.

KEY MARKET STATISTICS
Base Year [2023] USD 22.57 billion
Estimated Year [2024] USD 24.80 billion
Forecast Year [2030] USD 43.94 billion
CAGR (%) 9.98%

Despite growth potential, challenges such as high cost and stringent regulatory approvals may impede market expansion. Concerns over cybersecurity risks in connected devices and complications arising from device implants are also barriers. Limitations include regional disparities in healthcare access and the high cost of device and procedure, often unaffordable for patients in low-income regions. For sustained business growth, innovations should focus on improving device biocompatibility, enhancing battery longevity, and advancing remote monitoring capabilities. Additionally, exploring partnerships with tech firms for improved data analytics capabilities can present competitive advantages. The market is dynamic, with a mix of established players and new entrants, driving continuous R&D efforts. Companies should focus on developing comprehensive value propositions, including post-sale services and smart device solutions that integrate with broader healthcare systems. Leveraging these insights can guide strategic initiatives in fostering technological advancements and entering new markets.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidences of heart failures
    • Growing use of photoplethysmography technology in wearables for atrial fibrillation (AFib) detection
    • Rising investments and grants for research on CM & CRM devices
  • Market Restraints
    • Product recalls associated with cardiac rhythm management devices
  • Market Opportunities
    • Introduction of advanced cardiac rhythm management devices
    • Increasing expenditure on healthcare services
  • Market Challenges
    • Dearth of skilled professionals with knowledge and expertise in electrocardiography and cardiac

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Rhythm Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Rhythm Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Rhythm Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Rhythm Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Rhythm Management Devices Market

A detailed market share analysis in the Cardiac Rhythm Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Rhythm Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Rhythm Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Rhythm Management Devices Market

A strategic analysis of the Cardiac Rhythm Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Rhythm Management Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Asahi Kasei Corporation, Bexen Cardio, Biotronik SE & Co. KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, Defibtech LLC by Nihon Kohden Corporation, General Electric Company, HeartSine Technologies, Ltd. by Stryker Corporation, Hill-Rom Holdings, Inc. by Baxter International, Inc., Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co.,Ltd., Medtronic PLC, MicroPort Scientific Corporation, Narang Medical Ltd., TZ Medical, Inc., and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Rhythm Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Cardiac Resynchronization Therapy, Defibrillators, and Pacemakers. The Cardiac Resynchronization Therapy is further studied across CRT-Defibrillator and CRT-Pacemakers. The Defibrillators is further studied across External Defibrillator and Implantable Cardioverter Defibrillators. The External Defibrillator is further studied across Automatic External Defibrillator, Manual External Defibrillator, and Wearable Cardioverter Defibrillator. The Implantable Cardioverter Defibrillators is further studied across S-ICD and T-ICD. The Pacemakers is further studied across External and Implantable.
  • Based on End-User, market is studied across Ambulatory Surgery Centers and Hospitals, Clinics, & Cardiac Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidences of heart failures
      • 5.1.1.2. Growing use of photoplethysmography technology in wearables for atrial fibrillation (AFib) detection
      • 5.1.1.3. Rising investments and grants for research on CM & CRM devices
    • 5.1.2. Restraints
      • 5.1.2.1. Product recalls associated with cardiac rhythm management devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced cardiac rhythm management devices
      • 5.1.3.2. Increasing expenditure on healthcare services
    • 5.1.4. Challenges
      • 5.1.4.1. Dearth of skilled professionals with knowledge and expertise in electrocardiography and cardiac
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiac Rhythm Management Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Resynchronization Therapy
    • 6.2.1. CRT-Defibrillator
    • 6.2.2. CRT-Pacemakers
  • 6.3. Defibrillators
    • 6.3.1. External Defibrillator
      • 6.3.1.1. Automatic External Defibrillator
      • 6.3.1.2. Manual External Defibrillator
      • 6.3.1.3. Wearable Cardioverter Defibrillator
    • 6.3.2. Implantable Cardioverter Defibrillators
      • 6.3.2.1. S-ICD
      • 6.3.2.2. T-ICD
  • 6.4. Pacemakers
    • 6.4.1. External
    • 6.4.2. Implantable

7. Cardiac Rhythm Management Devices Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Centers
  • 7.3. Hospitals, Clinics, & Cardiac Centers

8. Americas Cardiac Rhythm Management Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Cardiac Rhythm Management Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Rhythm Management Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACS Diagnostics
  • 3. Alivecor, Inc.
  • 4. Asahi Kasei Corporation
  • 5. Bexen Cardio
  • 6. Biotronik SE & Co. KG
  • 7. Boston Scientific Corporation
  • 8. BPL Medical Technologies Private Limited
  • 9. Defibtech LLC by Nihon Kohden Corporation
  • 10. General Electric Company
  • 11. HeartSine Technologies, Ltd. by Stryker Corporation
  • 12. Hill-Rom Holdings, Inc. by Baxter International, Inc.
  • 13. Koninklijke Philips N.V.
  • 14. Lepu Medical Technology (Beijing) Co.,Ltd.
  • 15. Medtronic PLC
  • 16. MicroPort Scientific Corporation
  • 17. Narang Medical Ltd.
  • 18. TZ Medical, Inc.
  • 19. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIAC RHYTHM MANAGEMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIAC RHYTHM MANAGEMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CRT-DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CRT-PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY AUTOMATIC EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY MANUAL EXTERNAL DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY S-ICD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY T-ICD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS, CLINICS, & CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. INDONESIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. JAPAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. JAPAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. MALAYSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. MALAYSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. PHILIPPINES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SINGAPORE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SINGAPORE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. SOUTH KOREA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. TAIWAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. TAIWAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. THAILAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. THAILAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. VIETNAM CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. VIETNAM CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 174. DENMARK CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. DENMARK CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. EGYPT CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. EGYPT CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. FINLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. FINLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. FRANCE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. FRANCE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 202. GERMANY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. GERMANY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. ISRAEL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. ISRAEL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. ITALY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. ITALY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 223. NETHERLANDS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. NETHERLANDS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. NIGERIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. NIGERIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. NORWAY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. NORWAY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 244. POLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. POLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 251. QATAR CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. QATAR CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 258. RUSSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. RUSSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 265. SAUDI ARABIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. SAUDI ARABIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. SPAIN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. SPAIN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY CARDIAC RESYNCHRONIZATION THERAPY, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL DEFIBRILLATOR, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 286. SWEDEN CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. SWEDEN C